Infections in patients with inflammatory bowel disease receiving anti-tumor necrosis factor agents are not associated with higher serum drug levels

被引：0
|
作者：
Chu, I. E. [1 ,2 ]
Su, H. Y. [1 ,2 ]
Martin, C. [3 ]
Sparrow, M. P. [1 ,2 ]
机构：
[1] Alfred Hosp, Alfred Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [41] Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease Reply
    Bouguen, Guillaume
    Brunet, Tanguy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 855 - 856
  • [42] Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease A Cohort Study
    Cleynen, Isabelle
    Van Moerkercke, Wouter
    Billiet, Thomas
    Vandecandelaere, Pieter
    Vande Casteele, Niels
    Breynaert, Christine
    Ballet, Vera
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert
    Rutgeerts, Paul
    van den Oord, Joost J.
    Gils, Ann
    Segaert, Siegfried
    Vermeire, Severine
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (01) : 10 - +
  • [43] The role of anti-tumor necrosis factor-α therapy in Pyoderma gangrenosum associated with inflammatory bowel disease
    Reguiai, Ziad
    Grange, Florent
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (02) : 67 - 77
  • [44] The Role of Anti-Tumor Necrosis Factor-α Therapy in Pyoderma Gangrenosum Associated with Inflammatory Bowel Disease
    Ziad Reguiaï
    Florent Grange
    American Journal of Clinical Dermatology, 2007, 8 : 67 - 77
  • [45] High prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease receiving anti-tumor necrosis factor therapy
    Likhitsup, Alisa
    Dundulis, Jason
    Ansari, Shaya
    Patibandla, Sruthi
    Hutton, Colleen
    Kennedy, Kevin
    Helzberg, John H.
    Chhabra, Rajiv
    ANNALS OF GASTROENTEROLOGY, 2019, 32 (05): : 463 - +
  • [46] CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
    Nardelli, Andrea
    Marshall, John K.
    Chauhan, Usha
    Halder, Smita
    Tse, Frances
    Leontiadis, Grigorios I.
    Narula, Neeraj
    Albashir, Siwar M.
    Collins, Stephen M.
    Moayyedi, Paul
    Sanchez, Maria Ines Pinto
    Armstrong, David
    Surette, Michael
    Bercik, Premysl
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S676
  • [47] High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease
    Zvuloni, M.
    Matar, M.
    Levi, R.
    Shamir, R.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S395 - S395
  • [48] Pharmacokinetic Effect of Anti-tumor Necrosis Factor-alpha Agents on Thiopurine Drug Metabolism in Inflammatory Bowel Diseases
    Syal, Gaurav
    Bonthala, Nirupama
    Feldman, Edward J.
    Fleshner, Phillip
    McGovern, Dermot P. B.
    Vasiliauskas, Eric A.
    Melmed, Gil Y.
    Targan, Stephan R.
    Shih, David Q.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S383 - S384
  • [49] RISK OF POSTOPERATIVE COMPLICATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS TREATED PREOPERATIVELY WITH ANTI-INTEGRIN AND ANTI-TUMOR NECROSIS FACTOR AGENTS
    Yamada, Akihiro
    Komaki, Yuga
    Patel, Nayan
    Komaki, Fukiko
    Pekow, Joel R.
    Dalal, Sushila
    Cohen, Russell D.
    Cannon, Lisa
    Umanskiy, Konstantin
    Smith, Radhika
    Hurst, Roger
    Hyman, Neil
    Rubin, David T.
    Sakuraba, Atsushi
    GASTROENTEROLOGY, 2017, 152 (05) : S574 - S574
  • [50] Characterization of Anti-Tumor Necrosis Factor Agent-Induced Lupus in Patients With Inflammatory Bowel Disease
    Murdoch, Travis B.
    Stinton, Laura
    Panaccione, Remo
    Kaplan, Gilaad
    Ghosh, Subrata
    Anderson, Carl A.
    Eksteen, Bertus
    GASTROENTEROLOGY, 2014, 146 (05) : S585 - S585
12345